Market Cap

$13.5B

Volume

9.0M

Cash and Equivalents

$1.9B

EBITDA

$4.6B

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$6.3B

Profit Margin

42.03%

52 Week High

$13.62

52 Week Low

$9.93

Dividend

4.23%

Price / Book Value

0.68

Price / Earnings

-15.34

Price / Tangible Book Value

-1.75

Enterprise Value

$27.5B

Enterprise Value / EBITDA

5.89

Operating Income

$1.9B

Return on Equity

4.34%

Return on Assets

2.48

Cash and Short Term Investments

$2.0B

Debt

$16.0B

Equity

$19.8B

Revenue

$15.0B

Unlevered FCF

$4.5B

Sector

Pharmaceuticals

Category

N/A